Pleo Fort PORTABLE SIPS 5X, 10 x 1 mL Carton. Oral Homeopathic Medicine, OTC Only. Made in Germa...
FDA Drug Recall #D-1206-2014 — Class II — March 3, 2014
Recall Summary
| Recall Number | D-1206-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 3, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Terra-Medica Inc. |
| Location | Ferndale, WA |
| Product Type | Drugs |
| Quantity | 126 10 x 1 ml Cartons; 76 50 x 1ml Cartons |
Product Description
Pleo Fort PORTABLE SIPS 5X, 10 x 1 mL Carton. Oral Homeopathic Medicine, OTC Only. Made in Germany for: SANUM USA Copr, 1456 Slater Road, Ferndale, WA 98248 by Sanum-Kehlbeck GmbH & Co. KG. NDC: 49807-1105-1. Pleo Fort PORTABLE SIPS 5X, 50 x 1 mL Carton. Oral Homeopathic Medicine, OTC Only. Made in Germany for: SANUM USA Copr, 1456 Slater Road, Ferndale, WA 98248 by Sanum-Kehlbeck GmbH & Co. KG. NDC: 49807-1105-2.
Reason for Recall
Penicillin Cross Contamination.
Distribution Pattern
Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.
Lot / Code Information
10 x 1 ml Cartons: Batch # 15030; EXP: February 2015; Batch # 12122; EXP: November 2017. 50 x 1 ml: Batch # 15030; EXP: February 2015; Batch # 12122; EXP: November 2017.
Other Recalls from Terra-Medica Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1201-2014 | Class II | Pleo Quent CAPSULES 4X, 20 Capsule Cartons, Ora... | Mar 3, 2014 |
| D-1196-2014 | Class II | Pleo Not PORTABLE SIPS, 5X, 10 x 1mL Cartons, O... | Mar 3, 2014 |
| D-1202-2014 | Class II | Pleo Quent DROPS 5X, 10 mL Bottles, Oral Homeop... | Mar 3, 2014 |
| D-1197-2014 | Class II | Pleo Not PORTABLE SIPS, 6X, 10 x 1mL Cartons, O... | Mar 3, 2014 |
| D-1210-2014 | Class II | Pleo Ex DROPS 5X, 10 ml bottles, Homeopathic An... | Mar 3, 2014 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.